Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Sjogren’s syndrome treatment market was valued at USD 271.02 Million in 2024, driven by increasing incidence of autoimmune diseases across the globe. The market is expected to grow at a CAGR of 3.79% during the forecast period of 2025-2034, with the values likely to reach USD 393.15 Million by 2034.

2024

Base Year

2018-2024

Historical Period

2025-2034

Forecast Period

  • The demand for Sjogren’s syndrome treatment is on the rise, due to heightened awareness and ongoing clinical trials to find a treatment for the condition.

  • One of the major market trends includes rising research and development to provide optimized solutions for patients.

  • The North America region is likely to experience notable growth in the forecast period.

Compound Annual Growth Rate

3.79%

Value in USD Million

2025-2034


*this image is indicative*

Sjogren’s Syndrome Treatment Market Overview

Sjogren’s syndrome is a chronic autoimmune disease characterized by the immune system attacking the glands responsible for production of tears and saliva. This condition results in dry eye and dry mouth (also known as sicca symptoms). Nevertheless, it can also affect other body parts like lungs, kidneys, joints, and nerves etc. leading to wide range of symptoms and complications. The treatment for the syndrome includes symptomatic treatment, biologic agents, immune system suppression, and lifestyle adjustments. Nearly 4 % of the world’s population is affected by one of more than 80 different autoimmune diseases.

Sjogren’s Syndrome Treatment Market Growth Drivers

Increasing Research and Development Activities

To curb the burden of the autoimmune disease, the market is witnessing increased research and development of new drugs. There is an increasing involvement of organizations in conducting clinical trials to produce a treatment for the syndrome to help the patients with Sjogren’s syndrome. In November 2023, Amgen presented data from phase 2 trial of dazodalibep, a CD40 ligand antagonist in Sjögren's syndrome at American College of Rheumatology. The clinical trial was a randomized, double-blind, placebo-controlled crossover study evaluating two Sjögren's populations. The findings from the study demonstrated positive results that dazodalibep may improve both the systemic and symptomatic disease burden of people living with Sjögren's syndrome.

Growth in Strategic Partnerships and Mergers to Meet Rising Sjogren’s Syndrome Treatment Market Demand

In February 2024, PrecisionLife and Metrodora Institute collaborated to diagnose and treat complex chronic diseases including long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more. Under the agreement, both partners aim to first develop and validate genotypic diagnostics to provide clinicians with an accurate view of patients’ risk of disease. This involves using molecular profiling to understand the underlying disease mechanisms. The insights are projected to help clinicians in making more informed prescribing decisions and identify new areas for drug discovery leading to improve patient outcomes.

Sjogren’s Syndrome Treatment Market Trends

Sjogren’s Syndrome Treatment Market Segmentation

The EMR’s report titled “Sjogren’s Syndrome Treatment Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Drug Class

  • Antimalarial Quinolines
  • Cholinergic Agents
  • Corticosteroids
  • Others

Market Breakup by Therapy Type

  • Targeted Drugs
  • Pain Relievers
  • Symptom Modulators
  • Vaccines
  • Surgery
  • Others

Market Breakup by Route of Administration

  • Oral
  • Intravenous
  • Subcutaneous
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
  • Japan
  • India

Sjogren’s Syndrome Treatment Market Share

Market Segmentation Based on Drug Class is Projected to Experience Substantial Growth

Based on drug class, the market segmentation includes antimalarial quinolines, cholinergic agents, corticosteroids among others. Antimalarial quinolones are majorly used for their anti-inflammatory properties that caters to the systemic symptoms of the syndrome. This segment is predicted to observe steady growth because of its efficacy in reducing skin rash and fatigue associated with the syndrome. To address the chief symptoms of Sjogren’s syndrome such as dry eyes and mouth, cholinergic agents are used as they stimulate the secretion of saliva. The demand for cholinergic agents is estimated to grow as the number of diagnosed cases are increasing, thereby increasing the requirement of symptomatic relief.

Corticosteroids are incorporated into the treatment regimen to control severe symptoms involving vital organs like kidneys and lungs. These medications are crucial in managing inflammation. Their use is limited to a short span of time as it can cause long term side effects.

Targeted Drug Therapy Expected to Lead the Market Share

Based on therapy type, the market constitutes targeted drugs, pain relievers, symptom modulators, vaccines, surgery, and others. Targeted drugs such as B cell-depleting agents and inhibitors of B cell activation offer precision treatment by aiming on molecular targets associated with the syndrome. To curb the pain and ease the symptoms, the pain relivers and symptom modulators are expected to witness significant growth. This is also attributed to the widespread use of symptom modulators are the primary concern for Sjogren’s syndrome is to get relief from the symptoms of dry mouth and dry eye. Surgical interventions, though less common, are crucial for severe cases where glandular functionality is heavily compromised.

Sjogren’s Syndrome Treatment Market Analysis by Region

Regionally, the market report offers an insight into United States, EU-4 (including Spain, France, Italy and Germany) along with the United Kingdom, Japan and India. Leading the market with advanced healthcare infrastructure and investments in research and development, United States is projected to hold a significant market share in the forecast period. Increasing incidence of clinical trials in the region is also driving market growth in the region. Surge in investments in healthcare research and government support for innovations is boosting Europe’s Sjogren’s syndrome treatment market. The region also has a well-established infrastructure along with high awareness of autoimmune diseases.

Leading Players in the Sjogren’s Syndrome Treatment Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Denali Therapeutics
  • Clovis Oncology
  • Horizon Therapeutics Plc
  • Sangamo Therapeutics
  • AbbVie Inc.
  • Advanz Pharma
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company, Limited
  • Hikma Pharmaceuticals PlC
  • Johnson and Johnson

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in the Sjogren’s Syndrome Treatment Market Report

  • What was the Sjogren’s syndrome treatment market value in 2023?
  • What is the Sjogren’s syndrome treatment market forecast outlook for 2025-2034?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on drug class?
  • What is the market breakup based on therapy type?
  • Who are the major distribution channels in the market?
  • What are the various route of administration in Sjogren’s syndrome treatment market?
  • What are the major factors aiding the Sjogren’s syndrome treatment market demand? 
  • How has the Sjogren’s syndrome treatment market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • How does the prevalence and incidence of autoimmune diseases affect the market landscape?
  • What are the major Sjogren’s Syndrome Treatment market trends?
  • What drug class will dominate the market share? 
  • Who are the key players involved in the Sjogren’s syndrome treatment market?
  • What is patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

Sjogren’s Syndrome Treatment Market Report Snapshots

Sjogren’s Syndrome Treatment Market Size

Sjogren’s Syndrome Treatment Market Growth

Sjogren’s Syndrome Treatment Market Trends

Sjogren’s Syndrome Treatment Market Share

Sjogren’s Syndrome Treatment Market Regional Analysis

Sjogren’s Syndrome Treatment Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2024
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Therapy Type
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Antimalarial Quinolines
  • Cholinergic Agents
  • Corticosteroids 
  • Others
Breakup by Therapy Type
  • Targeted Drugs
  • Pain Relievers
  • Symptom Modulators
  • Vaccines
  • Surgery
  • Others
Breakup by Route of Administration
  • Oral
  • Intravenous
  • Subcutaneous
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Breakup by Region
  • United States
  • EU-4 and the United Kingdom
  • Japan
  • India 
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Denali Therapeutics
  • Clovis Oncology
  • Horizon Therapeutics Plc
  • Sangamo Therapeutics
  • AbbVie Inc.
  • Advanz Pharma
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company, Limited
  • Hikma Pharmaceuticals PlC
  • Johnson and Johnson

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us